Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Confidential contracting

- PMLiVE

The changing role of the modern MSL

Medical science liaisons are engaging in broader conversations than ever before

- PMLiVE

The Maverick: giving medicines away free

Co-op biotech founder Andrew Hessel on how he wants to change the way medicines are discovered and paid for

- PMLiVE

The world is our laboratory

Janssen's Thomas Stark on his company's approach to innovation, collaboration and research

- PMLiVE

Up in smoke

The side-lining of efficacy in medical cannabis debates

- PMLiVE

Another setback for Teva’s laquinimod in MS

Side effects seen in two late-stage trials but development will continue

- PMLiVE

Baxalta inks $1.6bn immuno-oncology deal with Symphogen

Comes as the company's takeover negotiations with Shire continue

- PMLiVE

Ariad appoints new CEO

Paris Panayiotopoulos joins the US biotech from EMD Serono

Caligor Rx appoints Michael Dallmann as director of strategic planning

He brings experience from Cubist Pharmaceuticals and Peninsula Pharmaceuticals

- PMLiVE

Glenn Sblendorio to retire as president of The Medicines Company

He will be replaced as chief financial officer by William O’Connor

Shire Basingstoke

Shire deal with Baxalta predicted this week

Takeover talks reported to be at an advanced stage

- PMLiVE

Dr Hamina Patel moves from J&J to Evgen Pharma

She joins the drug development company as its chief medical officer

- PMLiVE

Chimerix hit as lead drug brincidofovir flunks trial

Antiviral failed to meet its objectives in late-stage study

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links